Results 81 to 90 of about 4,255,416 (197)

Erratum to: Ukraine’s foreign trade: responses to global challenges [PDF]

open access: yesSHS Web of Conferences, 2021
Radziyevska Svitlana, Us Ivan
doaj   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Transmèdia Storytelling: explorant el seu ús en l'educació

open access: yesTemes de Disseny, 2017
Les narratives transmèdia han transformat la manera en què s'imparteix la docència. És en aquest context on estudiants i professors poden expressar les seves experiències i les seves opinions utilitzant diverses eines de creació de continguts que ...
doaj  

Traçant universos femenins amb paper maixé: la tradició de Takamatsu-hariko en les col·leccions del Museu Etnològic de Barcelona

open access: yesDigithum, 2015
L’objectiu d’aquest article és traçar la biografia i mostrar l’ús social d’uns petits objectes de paper maixé pertanyents a la tradició de Takamatsu-hariko (Japó) que es conserven al Museu Etnològic de Barcelona.
Muriel Gómez Pradas
doaj  

Survivin and Aurora Kinase A control cell fate decisions during mitosis

open access: yesMolecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir   +2 more
wiley   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

Eduard Artells i la normativa: prescripció i ús

open access: yesEstudis Romànics
L’article descriu la posició d’Eduard Artells en el model de llengua literària dels anys seixanta, com veia el paper del corrector i les polèmiques més importants que la seva manera de treballar li va comportar.
Alexis Llobet
doaj  

Home - About - Disclaimer - Privacy